The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (22.33) EUR. With the latest stock price at 1.28 EUR, the upside of Cellectis SA based on DCF is -1844.7%.
Based on the latest price of 1.28 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 1844.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.5% | 6.3% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (209.39) - (12.03) | (22.33) |
| Upside | -16458.3% - -1040.0% | -1844.7% |